Andere talen Sedana Medical AB

Aandelen

SEDANA

SE0015988373

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:58 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
22,35 ^SEK	-1,54%		+8,23%	-3,50%

25/04	Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024
25/04	Sedana Medical AB (publ) rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sedana Medical Q1 - Set to beat conservative sales target	26/04
Sedana Medical AB's Interim report January-March 2024	25/04
Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US	25/04
Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US	25/04
Notice of Annual General Meeting in Sedana Medical	22/04
Ola Magnusson and Eva Walde Decline Re-Election as Board Members of Sedana Medical AB	22/04
Sedana Medical publishes its Annual Report for 2023	15/04
Invitation to presentation of Sedana Medical's interim report for the first quarter 2024	05/04
Sedana Medical Q4 - Likely to beat conservative 2024 sales target	16/02
Sedana Medical AB's Year-end report 2023	15/02
Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Sedana Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Invitation to presentation of Sedana Medical's fourth quarter and year-end report for 2023	25/01
Sedana Medical Seeks Pediatric Indication for Sedaconda Medical Device	20/12
Sedana Medical files submission for paediatric indication	20/12
Sedana Medical AB Files Submission for Paediatric Indication	20/12
Sedana Medical’s Sedaconda Gains Data Exclusivity, Market Protection in Europe	22/11
Sedana Medical secures data exclusivity and market protection for Sedaconda[®] (isoflurane) until 2031	22/11
Sedana Medical Secures Data Exclusivity and Market Protection for Sedaconda Until 2031	22/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sedana Medical AB

Aandelen

SEDANA

SE0015988373

Andere talen

Filters